Back to top

Image: Bigstock

Compared to Estimates, Cognizant (CTSH) Q1 Earnings: A Look at Key Metrics

Read MoreHide Full Article

For the quarter ended March 2025, Cognizant (CTSH - Free Report) reported revenue of $5.12 billion, up 7.5% over the same period last year. EPS came in at $1.23, compared to $1.12 in the year-ago quarter.

The reported revenue represents a surprise of +0.95% over the Zacks Consensus Estimate of $5.07 billion. With the consensus EPS estimate being $1.19, the EPS surprise was +3.36%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Cognizant performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Revenue- Financial services: $1.46 billion versus the two-analyst average estimate of $1.43 billion. The reported number represents a year-over-year change of +5.6%.
  • Revenue- Communications, Media and Technology: $804 million versus $833.33 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -2.7% change.
  • Revenue- Products and Resources: $1.28 billion versus $1.27 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +12.8% change.
  • Revenue- Health Sciences: $1.57 billion versus $1.55 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +11% change.
View all Key Company Metrics for Cognizant here>>>

Shares of Cognizant have returned -4.1% over the past month versus the Zacks S&P 500 composite's -0.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Cognizant Technology Solutions Corporation (CTSH) - free report >>

Published in